Cogent Biosciences, Inc. financial data

Symbol
COGT on Nasdaq
Industry
Pharmaceutical Preparations
Location
275 Wyman Street, 3 Rd Floor, Waltham, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Unum Therapeutics Inc. (to 10/5/2020), Unum Therapeutics, Inc. (to 3/30/2018)
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 985 % -12.6%
Debt-to-equity 15.5 % -2.71%
Return On Equity -63.7 % -17.1%
Return On Assets -55.2 % -17.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 95.6M shares +36.7%
Common Stock, Shares, Outstanding 95.6M shares +34.8%
Entity Public Float 968M USD +70.5%
Common Stock, Value, Issued 96K USD +35.2%
Weighted Average Number of Shares Outstanding, Basic 94.8M shares +34%
Weighted Average Number of Shares Outstanding, Diluted 94.8M shares +34%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 190M USD +44%
General and Administrative Expense 36.9M USD +34.3%
Costs and Expenses 227M USD +42.4%
Operating Income (Loss) -227M USD -42.4%
Nonoperating Income (Expense) 15.1M USD +31.9%
Net Income (Loss) Attributable to Parent -212M USD -43.2%
Earnings Per Share, Basic -2.49 USD/shares -10.2%
Earnings Per Share, Diluted -2.49 USD/shares -10.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 216M USD +34.3%
Assets, Current 442M USD +95.3%
Property, Plant and Equipment, Net 7.82M USD -13.5%
Operating Lease, Right-of-Use Asset 21.5M USD -6.88%
Other Assets, Noncurrent 4.86M USD +1.82%
Assets 476M USD +80.9%
Accounts Payable, Current 15.6M USD +273%
Employee-related Liabilities, Current 2.43M USD +11.8%
Liabilities, Current 36.7M USD +73.7%
Operating Lease, Liability, Noncurrent 17.1M USD -7.69%
Liabilities 53.8M USD +35.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -39K USD -344%
Retained Earnings (Accumulated Deficit) -662M USD -47.2%
Stockholders' Equity Attributable to Parent 422M USD +88.9%
Liabilities and Equity 476M USD +80.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -52.5M USD -32.9%
Net Cash Provided by (Used in) Financing Activities 214M USD +48003%
Net Cash Provided by (Used in) Investing Activities 1.04M USD -98.3%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 95.6M shares +34.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 163M USD +681%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 216M USD +33.2%
Deferred Tax Assets, Valuation Allowance 157M USD +75.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 18.9M USD -4.05%
Payments to Acquire Property, Plant, and Equipment 70K USD -93.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -212M USD -43.2%
Lessee, Operating Lease, Liability, to be Paid 28M USD -8.27%
Property, Plant and Equipment, Gross 12M USD +30.8%
Operating Lease, Liability, Current 1.43M USD +51.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.84M USD +2.19%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.78M USD +9.28%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.16M USD -13.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.7M USD -5.07%
Deferred Tax Assets, Operating Loss Carryforwards 48M USD +32.6%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.13M USD -20.9%
Operating Lease, Payments 3.54M USD -58%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 34.2M USD +70.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%